July 09, 2014

FDA Approves Kerydin (tavaborole) Topical Solution for Onychomycosis of the Toenails

"I am very excited about the release of this therapy for an infection that is very difficult to treat," said Boni Elewski, M.D., Vice Chair of Clinical Affairs and Professor of Dermatology at the University of Alabama at Birmingham. "Kerydin will offer patients a new, safe and effective treatment option for onychomycosis."

UAB in the News

 
 
Back to Top